Thc Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended April 30, 2020
June 22, 2020 at 03:45 pm EDT
Share
THC Therapeutics, Inc. announced earnings results for the third quarter ended April 30, 2020. For the third quarter, the company announced operating loss was USD 511,071 compared to USD 18.693 million a year ago. Net loss was USD 1.260 million compared to USD 22.131 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 1.69 a year ago. For the nine months, operating loss was USD 1.078 million compared to USD 21.798 million a year ago. Net loss was USD 2.272 million compared to USD 26.113 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 2 a year ago.
THC Therapeutics, Inc. is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The Company operates in the wellness industry.
THC THERAPEUTICS, INC. 
